[1]. Z. Fatima, M. Idrees, M. A. Bajwa, Z. Tahir, O. Ullah, M. Q. Zia, A. Hussain, M. Akram, B. Khubaib, S. Afzal and S. Muni, Serotype and genotype analysis of dengue virus by sequencing followed by phylogenetic analysis using samples from three mini outbreaks-2007-2009 in Pakistan. BMC microbiology, 11 (2011) 1-8.
[2]. M. G. Guzman, M. Alvarez and S. B. Halstead, Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Archives of virology, 158 (2013) 1445-59.
[3]. M E. Beatty, A. Stone, D. W. Fitzsimons, J. N. Hanna, S. K. Lam, S. Vong, M. G. Guzman, J. F. Mendez-Galvan, S. B. Halstead, G. W. Letson, J. Kuritsky, Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards. PLoS neglected tropical diseases, 4 (2010) e890.
[4]. S. P. Lim, C. G. Noble, C. C. Seh, T. S. Soh, A. El Sahili, G. K. Chan, J. Lescar, R. Arora, T. Benson, S. Nilar and U. Manjunatha, Potent allosteric dengue virus NS5 polymerase inhibitors: mechanism of action and resistance profiling. PLoS pathogens, 12 (2016) e1005737.
[5]. A. Samimi, S. Zarinabadi, A. Bozorgian, Optimization of Corrosion Information in Oil and Gas Wells Using Electrochemical Experiments, International Journal of New Chemistry, 8 (2021), 149-163.
[6]. S. P.Lim, Q. Y. Wang, C. G. Noble, Y. L. Chen, H. Dong, B. Zou, F. Yokokawa, S. Nilar, P. Smith, D. Beer and J. Lescar, Ten years of dengue drug discovery: progress and prospects. Antiviral research, 100 (2013) 500-19.
[7]. T. T. Nguyen, S. Lee, H. K. Wang, H. Y. Chen, Y. T. Wu, S. C. Lin, D. W. Kim and D. Kim, In vitro evaluation of novel inhibitors against the NS2B-NS3 protease of dengue fever virus type 4. Molecules, 18 (2013) 15600-12.
[8]. R. E. Blanton, L. K. Silva, V. G. Morato, A. R. Parrado, J. P. Dias, P. R. Melo, E. A. Reis, K. A. Goddard, M. R. Nunes, S. G. Rodrigues and P. F. Vasconcelos, Genetic ancestry and income are associated with dengue hemorrhagic fever in a highly admixed population. European Journal of Human Genetics, 16 (2008) 762-5.
[9]. A. Guzman and R. E. Istúriz, Update on the global spread of dengue. International journal of antimicrobial agents, 36 (2010) S40-2.
[10]. P. D. Zanotto, E. A. Gould, G. F. Gao, P. H. Harvey and E. C. Holmes, Population dynamics of flaviviruses revealed by molecular phylogenies, Proceedings of the National Academy of Sciences, 93 (1996) 548-53.
[11]. A. Balasubramanian, T. Teramoto, A. A. Kulkarni, A. K. Bhattacharjee and R. Padmanabhan, Antiviral activities of selected antimalarials against dengue virus type 2 and Zika virus. Antiviral research, 137 (2017) 141-50.
[12]. A. Bozorgian, B. Raei, Thermodynamic modeling and phase prediction for binary system dinitrogen monoxide and propane, Journal of Chemistry Letters 1 (2020) 143-148.
[13]. D. Bardiot, M. Koukni, W. Smets, G. Carlens, M. McNaughton, S. Kaptein, K. Dallmeier, P. Chaltin, J. Neyts and A. Marchand, Discovery of indole derivatives as novel and potent dengue virus inhibitors. Journal of Medicinal Chemistry, 61 (2018) 8390-401.
[14]. M. Bagheri Sadr, A. Bozorgian, An Overview of Gas Overflow in Gaseous Hydrates, Journal of Chemical Reviews 3 (2021), 66-82
[15]. A. Daina, O. Michielin and V. Zoete, SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific reports. 7 (2017) 1-3.
[16]. S. N. Adawara, G. A. Shallangwa, P. A. Mamza and A. Ibrahim, Molecular docking and QSAR theoretical model for prediction of phthalazinone derivatives as new class of potent dengue virus inhibitors. Beni-Suef University Journal of Basic and Applied Sciences, 9(2020) 1-7.
[17]. W. J. Hehre and W. W. Huang, Chemistry with computation: an introduction to SPARTAN. Wavefunction, Incorporated, 1995.
[18]. A. Bozorgian, Investigation of the effect of Zinc Oxide Nano-particles and Cationic Surfactants on Carbon Dioxide Storage capacity, Advanced Journal of Chemistry, Section B: Natural Products and Medical Chemistry, 3 (2021) 54-61.
[19]. S. N. Adawara, G. A. Shallangwa, P. A. Mamza and A. Ibrahim, In Silico Studies of Oxadiazole Derivatives as Potent Dengue Virus Inhibitors. Chemistry Africa, 4 (2021) 861-8.
[20]. P Ambure, R. B. Aher, A. Gajewicz, T. Puzyn and K. Roy, “NanoBRIDGES” software: open access tools to perform QSAR and nano-QSAR modeling. Chemometrics and Intelligent Laboratory Systems, 15 (2015) 1-3.
[21]. S. B. Olasupo, A. Uzairu, G. A. Shallangwa and S. Uba, QSAR modeling, molecular docking and ADMET/pharmacokinetic studies: a chemometrics approach to search for novel inhibitors of norepinephrine transporter as potent antipsychotic drugs. Journal of the Iranian Chemical Society, 17 (2020) 1953-66.
[22]. J. H. Friedman, Multivariate adaptive regression splines. The annals of statistics, 19 (1991) 1-67.
[23]. R. Veerasamy, H. Rajak, A. Jain, S. Sivadasan, C. P. Varghese and R. K. Agrawal, Validation of QSAR models-strategies and importance. Int. J. Drug Des. Discov, 3 (2011) 511-9.
[24]. A. Bozorgian, Investigation of Hydrate Formation Kinetics and Mechanism of Effect of Inhibitors on it, a Review, Journal of Chemical Reviews, 3 (2021), 50-65.
[25]. D. Weintrop, E. Beheshti, M. Horn, K. Orton, K. Jona, L. Trouille and U. Wilensky, Defining computational thinking for mathematics and science classrooms. Journal of Science Education and Technology, 25 (2016) 127-47.
[26]. N. Nikolova and J. Jaworska, Approaches to measure chemical similarity–a review. QSAR & Combinatorial Science, 22 (2003) 1006-26.
[27]. A. Golbraikh, X. S. Wang, H. Zhu and A. Tropsha, Predictive QSAR modeling methods and applications in drug discovery and chemical risk assessment. Handbook of computational chemistry, 1 (2012) 1309-42.
[28]. T. I. Netzeva, A. P. Worth, T. Aldenberg, R. Benigni, M. T. Cronin, P. Gramatica, J. S. Jaworska, S. Kahn, G. Klopman, C. A. Marchant and G. Myatt, Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships: The report and recommendations of ecvam workshop 52. Alternatives to Laboratory Animals, 33(2): (2015) 155-73.
[29]. S. Dimitrov, G. Dimitrova, T. Pavlov, N. Dimitrova, G. Patlewicz, J. Niemela and O. Mekenyan, A stepwise approach for defining the applicability domain of SAR and QSAR models. Journal of chemical information and modeling, 45(4) (2005) 839-49.
[30]. D. E. Pires, T. L. Blundell, and D. B. Ascher, pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem., 58 (2015) 4066-72.
[31]. V. Consonni and R. Todeschini, Molecular Descriptors for Chemoinformatics: Volume I: Alphabetical Listing/Volume II: Appendices, References. John Wiley & Sons; 2009.